15-Hydroxyprostaglandin Dehydrogenase-derived 15-Keto-prostaglandin E2Inhibits Cholangiocarcinoma Cell Growth through Interaction with Peroxisome Proliferator-activated Receptor-γ, SMAD2/3, and TAP63 Proteins
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
15-Hydroxyprostaglandin Dehydrogenase-derived 15-Keto-prostaglandin E2Inhibits Cholangiocarcinoma Cell Growth through Interaction with Peroxisome Proliferator-activated Receptor-γ, SMAD2/3, and TAP63 Proteins
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 288, Issue 27, Pages 19484-19502
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2013-05-17
DOI
10.1074/jbc.m113.453886
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Expression and Regulation of the ΔN and TAp63 Isoforms in Salivary Gland Tumorigenesis
- (2011) Yoshitsugu Mitani et al. AMERICAN JOURNAL OF PATHOLOGY
- Prostaglandin catabolic enzymes as tumor suppressors
- (2011) Hsin-Hsiung Tai CANCER AND METASTASIS REVIEWS
- Regulation of p63 Isoforms by Snail and Slug Transcription Factors in Human Squamous Cell Carcinoma
- (2010) Michael Herfs et al. AMERICAN JOURNAL OF PATHOLOGY
- Loss of 15-Hydroxyprostaglandin Dehydrogenase Expression Contributes to Bladder Cancer Progression
- (2010) Stephanie Tseng-Rogenski et al. AMERICAN JOURNAL OF PATHOLOGY
- p63in Epithelial Survival, Germ Cell Surveillance, and Neoplasia
- (2010) Christopher P. Crum et al. Annual Review of Pathology-Mechanisms of Disease
- The role of p63 in epidermal morphogenesis and neoplasia: Figure 1
- (2010) Simon S. McDade et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Association of hydroxyprostaglandin dehydrogenase 15-(NAD) (HPGD) variants and colorectal cancer risk
- (2010) B. Frank et al. CARCINOGENESIS
- Role of ΔNp63γ in Epithelial to Mesenchymal Transition
- (2010) Jaime Lindsay et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TAp63 suppresses metastasis through coordinate regulation of Dicer and miRNAs
- (2010) Xiaohua Su et al. NATURE
- Reduction of 15-hydroxyprostaglandin dehydrogenase expression is an independent predictor of poor survival associated with enhanced cell proliferation in gastric adenocarcinoma
- (2009) Hiroshi Tatsuwaki et al. CANCER SCIENCE
- HGF/Met signalling promotes PGE2 biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells
- (2009) A. E. Moore et al. CARCINOGENESIS
- β-tting on p63 as a Metastatic Suppressor
- (2009) John G. Clohessy et al. CELL
- A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
- (2009) Maddalena Adorno et al. CELL
- 15-Hydroxyprostaglandin Dehydrogenase Is Down-regulated in Gastric Cancer
- (2009) A. Thiel et al. CLINICAL CANCER RESEARCH
- p63 Suppresses Non-epidermal Lineage Markers in a Bone Morphogenetic Protein-dependent Manner via Repression of Smad7
- (2009) Laura De Rosa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Altered Expression of 15-Hydroxyprostaglandin Dehydrogenase in Tumor-Infiltrated CD11b Myeloid Cells: A Mechanism for Immune Evasion in Cancer
- (2009) E. Eruslanov et al. JOURNAL OF IMMUNOLOGY
- Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement
- (2009) Jack Cuzick et al. LANCET ONCOLOGY
- Experimental cancer therapy using restoration of NAD+-linked 15-hydroxyprostaglandin dehydrogenase expression
- (2009) L. N. Kaliberova et al. MOLECULAR CANCER THERAPEUTICS
- TAp63 induces senescence and suppresses tumorigenesis in vivo
- (2009) Xuecui Guo et al. NATURE CELL BIOLOGY
- Plk1 regulates liver tumor cell death by phosphorylation of TAp63
- (2009) S Komatsu et al. ONCOGENE
- The role of COX-2 in intestinal inflammation and colorectal cancer
- (2009) D Wang et al. ONCOGENE
- 15-Hydroxyprostaglandin dehydrogenase inactivation as a mechanism of resistance to celecoxib chemoprevention of colon tumors
- (2009) M. Yan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural evolution of p53, p63, and p73: Implication for heterotetramer formation
- (2009) A. C. Joerger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- p63 and p73 Transcriptionally Regulate Genes Involved in DNA Repair
- (2009) Yu-Li Lin et al. PLoS Genetics
- Repression of 15-Hydroxyprostaglandin Dehydrogenase Involves Histone Deacetylase 2 and Snail in Colorectal Cancer
- (2008) M. G. Backlund et al. CANCER RESEARCH
- Nonsteroidal Anti-inflammatory Drugs Suppress Glioma via 15-Hydroxyprostaglandin Dehydrogenase
- (2008) N. Wakimoto et al. CANCER RESEARCH
- 15-Hydroxyprostaglandin Dehydrogenase is a Target of Hepatocyte Nuclear Factor 3 and a Tumor Suppressor in Lung Cancer
- (2008) G. Huang et al. CANCER RESEARCH
- Cyclooxygenase-2 Derived Prostaglandin E2 Activates -Catenin in Human Cholangiocarcinoma Cells: Evidence for Inhibition of These Signaling Pathways by 3 Polyunsaturated Fatty Acids
- (2008) K. Lim et al. CANCER RESEARCH
- Expression of 15-PGDH is downregulated by COX-2 in gastric cancer
- (2008) Z. Liu et al. CARCINOGENESIS
- Nuclear receptors, transcription factors linking lipid metabolism and immunity: the case of peroxisome proliferator-activated receptor gamma
- (2008) T. Varga et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started